Sinus Lift Using PTFE Titanium Reinforced Membrane

September 6, 2021 updated by: Hams Hamed Abdelrahman

Evaluation of Direct Sinus Lift Using Ptfe Titanium Reinfored Membrane Assosiated With Immediate Implant Placement (Clinical Trial)

Various attempts have been implemented using different materials and techniques to augment the maxillary sinus floor enhancing autogenous bone formation to allow proper dental implant positioning. The aim of this study is to evaluate the sinus lift procedure using polytetrafluoroethylene (PTFE) titanium-reinforced membrane to maintain the space formed after Schneiderian membrane elevation followed by immediate implant placement.

Study Overview

Status

Active, not recruiting

Conditions

Study Type

Interventional

Enrollment (Anticipated)

12

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Alexandria, Egypt
        • Alexandria Faculty of Dentistry

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

36 years to 56 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patients of both genders requiring implant placement in posterior maxilla
  • Age range: 40-60 years.
  • Good oral hygiene
  • Healthy maxillary sinus free from pathology
  • The minimum crestal bone height is (4-6) mm
  • Patients who are willing and fully capable to comply with the study protocol.

Exclusion Criteria:

  • Sinus infection
  • Tumors or pathologic lesions in sinus
  • Severe allergic rhinitis.
  • Chronic topical steroid use.
  • Radiation therapy.
  • Psychologic / mental impairment
  • Acute infection (periodontitis or mucosal infection
  • Patients on radiotherapy or chemotherapy.
  • Alcohol or drug abuse.
  • Patient with systemic disorder (uncontrolled Diabetes mellitus, autoimmune diseases, bone diseases, etc.)
  • Smokers
  • Parafuctional habits

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Direct Sinus elevation using SLA Kit
Implants will be placed immediately after sinus lifting procedure and maintaining the sinus membrane in position using PTFE titanium reinforced membrane.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in implant stability
Time Frame: at baseline and 6 months
It will be measured using Osstell
at baseline and 6 months
Change in bone formation
Time Frame: at baseline and 6 months
It will be measured uisng CBCT on Demand 3d software
at baseline and 6 months
Change in bone height
Time Frame: at baseline and 6 months
It will be measured uisng CBCT on Demand 3d software
at baseline and 6 months
Change in bone density
Time Frame: at baseline and 6 months
It will be measured uisng CBCT on Demand 3d software
at baseline and 6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 1, 2020

Primary Completion (Anticipated)

October 20, 2021

Study Completion (Anticipated)

October 20, 2021

Study Registration Dates

First Submitted

September 6, 2021

First Submitted That Met QC Criteria

September 6, 2021

First Posted (Actual)

September 14, 2021

Study Record Updates

Last Update Posted (Actual)

September 14, 2021

Last Update Submitted That Met QC Criteria

September 6, 2021

Last Verified

September 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • sinus_lift2020

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Sinus Lift

Clinical Trials on Direct sinus lift with titanium reinforced PTFE membrane

Subscribe